Carbohydrate and lipid substrate changes associated with fasting were similar in aged (over 24 months), 1 -year-old and young (about 4 months old) rats. In all three age-groups fasting reduced liver and skeletal muscle glycogen, elevated myocardial glycogen and plasma free fatty acid (FFA) levels, but did not significantly affect blood glucose. With refeeding, the myocardium from aged and 1-year-old rats lacked the glycogenesis observed in young rats. Less glycogenesis was also observed in aged soleus muscles during refeeding than in soleus muscles from young or 1 -year-old rats. This depressed glycogenesis in the old rats could not be attributed to any change in the tissue triglyceride or plasma FFA response to refeeding, but was accompanied by a slightly greater elevation of glucagon in the aged rats. Though its etiology is unclear, the depressed glycogenesis indicates that aging affects aspects of carbohydrate metabolism in addition to the known decrease in glucose tolerance.

Keywords:
Rat, Fasting, Muscle glycogen, Liver glycogen, Blood glucose, Blood FFA, Muscle triglycerides
This content is only available via PDF.
© 1982 S. Karger AG, Basel
1982
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.